Editorial: Cellular Mechanisms of Ototoxicity

por Steyger, Peter S., Cunningham, Lisa L., Esquivel, Carlos R., Watts, Kelly L., Zuo, Jian
Publicado 2018

A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead

por Horgan, Claire, Watts, Kelly, Ram, Dipak, Rust, Stewart, Hutton, Rebekah, Jones, Simon, Wynn, Rob
Publicado 2023

Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience

por Howell, Jennifer C., Parker, Monica W., Watts, Kelly D., Kollhoff, Alexander, Tsvetkova, Dobromira Z., Hu, William T.
Publicado 2016

High‐resolution metabolomic profiling of Alzheimer’s disease in plasma

por Niedzwiecki, Megan M., Walker, Douglas I., Howell, Jennifer Christina, Watts, Kelly D., Jones, Dean P., Miller, Gary W., Hu, William T.
Publicado 2019

Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers

por Howell, Jennifer C., Watts, Kelly D., Parker, Monica W., Wu, Junjie, Kollhoff, Alexander, Wingo, Thomas S., Dorbin, Cornelya D., Qiu, Deqiang, Hu, William T.
Publicado 2017

CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?

por Hu, William T, Watts, Kelly D, Shaw, Leslie M, Howell, Jennifer C, Trojanowski, John Q, Basra, Sundeep, Glass, Jonathan D, Lah, James J, Levey, Allan I
Publicado 2015

Fear and Uncertainty Do Not Influence Reported Willingness to Undergo Lumbar Punctures in a U.S. Multi-Cultural Cohort

por Tsvetkova, Dobromira Z., Bergquist, Sharon H., Parker, Monica W., Jarrett, Thomas L., Howell, Jennifer C., Watts, Kelly D., Kollhoff, Alexander, Roberts, David L., Hu, William T.
Publicado 2017

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

por del Campo, Marta, Galimberti, Daniela, Elias, Naura, Boonkamp, Lynn, Pijnenburg, Yolande A., van Swieten, John C., Watts, Kelly, Paciotti, Silvia, Beccari, Tommaso, Hu, William, Teunissen, Charlotte E.
Publicado 2018

CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease

por Hu, William T., Watts, Kelly D., Tailor, Prashant, Nguyen, Trung P., Howell, Jennifer C., Lee, Raven C., Seyfried, Nicholas T., Gearing, Marla, Hales, Chadwick M., Levey, Allan I., Lah, James J., Lee, Eva K.
Publicado 2016

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

por Gangishetti, Umesh, Christina Howell, J., Perrin, Richard J., Louneva, Natalia, Watts, Kelly D., Kollhoff, Alexander, Grossman, Murray, Wolk, David A., Shaw, Leslie M., Morris, John C., Trojanowski, John Q., Fagan, Anne M., Arnold, Steven E., Hu, William T.
Publicado 2018